Lee KW, Zang DY, Kim HD, Kim JW, et al. Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer. Br J Cancer 2025 Jun 20. doi: 10.1038/s41416-025-03092.
PMID: 40542173